Investigating the effect of chicory in the treatment of thalassemia

Phase 3

Recruiting

• Conditions: Beta Thalassemia major.; Beta thalassemia; D56.1

• Registration Number: IRCT20230704058674N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Consent of patients to participate in the study
thalassemia major patients treated with periodic pack cell transfusion
ferritin>500

Exclusion Criteria

disinclination to participate or continue studying
Occurrence of skin complications or other symptoms suggestive of sensitivity to chicory plant extract
Viral hepatitis or known liver disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ferritin. Timepoint: Initial ferritin measurement (before the start of the intervention), 3 months after consumption of chicory. Method of measurement: Biochemistry blood test.

Secondary Outcome Measures

Name	Time	Method
iver enzyme. Timepoint: Liver enzyme measurement at the beginning of the study (before consuming chicory) and three months after consuming chicory. Method of measurement: Biochemistry blood test.